Literature DB >> 29212904

Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.

Joanne A O'Donnell1, Jesse Lehman1, Justine E Roderick1, Dalia Martinez-Marin1, Matija Zelic1, Ciara Doran1, Nicole Hermance1, Stephen Lyle1, Manolis Pasparakis2,3, Katherine A Fitzgerald4, Ann Marshak-Rothstein4, Michelle A Kelliher5.   

Abstract

Necroptosis is a form of cell death associated with inflammation; however, the biological consequences of chronic necroptosis are unknown. Necroptosis is mediated by RIPK1, RIPK3, and MLKL kinases but in hematopoietic cells RIPK1 has anti-inflammatory roles and functions to prevent necroptosis. Here we interrogate the consequences of chronic necroptosis on immune homeostasis by deleting Ripk1 in mouse dendritic cells. We demonstrate that deregulated necroptosis results in systemic inflammation, tissue fibrosis, and autoimmunity. We show that inflammation and autoimmunity are prevented upon expression of kinase inactive RIPK1 or deletion of RIPK3 or MLKL. We provide evidence that the inflammation is not driven by microbial ligands, but depends on the release of danger-associated molecular patterns and MyD88-dependent signaling. Importantly, although the inflammation is independent of type I IFN and the nucleic acid sensing TLRs, blocking these pathways rescues the autoimmunity. These mouse genetic studies reveal that chronic necroptosis may underlie human fibrotic and autoimmune disorders.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29212904      PMCID: PMC5760320          DOI: 10.4049/jimmunol.1701229

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

Review 1.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.

Authors:  Bruce Beutler; Zhengfan Jiang; Philippe Georgel; Karine Crozat; Ben Croker; Sophie Rutschmann; Xin Du; Kasper Hoebe
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

2.  The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

Authors:  James M Murphy; Peter E Czabotar; Joanne M Hildebrand; Isabelle S Lucet; Jian-Guo Zhang; Silvia Alvarez-Diaz; Rowena Lewis; Najoua Lalaoui; Donald Metcalf; Andrew I Webb; Samuel N Young; Leila N Varghese; Gillian M Tannahill; Esme C Hatchell; Ian J Majewski; Toru Okamoto; Renwick C J Dobson; Douglas J Hilton; Jeffrey J Babon; Nicos A Nicola; Andreas Strasser; John Silke; Warren S Alexander
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

3.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

4.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

5.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.

Authors:  Christopher P Dillon; Ricardo Weinlich; Diego A Rodriguez; James G Cripps; Giovanni Quarato; Prajwal Gurung; Katherine C Verbist; Taylor L Brewer; Fabien Llambi; Yi-Nan Gong; Laura J Janke; Michelle A Kelliher; Thirumala-Devi Kanneganti; Douglas R Green
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

7.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

8.  Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.

Authors:  Lukas Bossaller; Vijay A K Rathinam; Ramon Bonegio; Ping-I Chiang; Patricia Busto; Adam R Wespiser; Daniel R Caffrey; Quan-Zhen Li; Chandra Mohan; Katherine A Fitzgerald; Eicke Latz; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

9.  Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells.

Authors:  Jennifer A Young; Tina H He; Boris Reizis; Astar Winoto
Journal:  Cell Rep       Date:  2013-05-30       Impact factor: 9.423

10.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

View more
  14 in total

1.  Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.

Authors:  Chaohuan Guo; Rong Fu; Mianjing Zhou; Shuang Wang; Yuefang Huang; Haoqiang Hu; Jijun Zhao; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  J Autoimmun       Date:  2019-05-24       Impact factor: 7.094

Review 2.  Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.

Authors:  A Justin Rucker; Francis Ka-Ming Chan
Journal:  Trends Biochem Sci       Date:  2022-01-05       Impact factor: 13.807

3.  ZBP1 promotes inflammatory responses downstream of TLR3/TLR4 via timely delivery of RIPK1 to TRIF.

Authors:  Hayley I Muendlein; Wilson M Connolly; Zoie Magri; David Jetton; Irina Smirnova; Alexei Degterev; Siddharth Balachandran; Alexander Poltorak
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-06       Impact factor: 12.779

4.  Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases.

Authors:  Yue Li; Marita Führer; Ehsan Bahrami; Piotr Socha; Maja Klaudel-Dreszler; Amira Bouzidi; Yanshan Liu; Anna S Lehle; Thomas Magg; Sebastian Hollizeck; Meino Rohlfs; Raffaele Conca; Michael Field; Neil Warner; Slae Mordechai; Eyal Shteyer; Dan Turner; Rachida Boukari; Reda Belbouab; Christoph Walz; Moritz M Gaidt; Veit Hornung; Bernd Baumann; Ulrich Pannicke; Eman Al Idrissi; Hamza Ali Alghamdi; Fernando E Sepulveda; Marine Gil; Geneviève de Saint Basile; Manfred Hönig; Sibylle Koletzko; Aleixo M Muise; Scott B Snapper; Klaus Schwarz; Christoph Klein; Daniel Kotlarz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

5.  Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis.

Authors:  Joseph Sarhan; Beiyun C Liu; Hayley I Muendlein; Chi G Weindel; Irina Smirnova; Amy Y Tang; Vladimir Ilyukha; Maxim Sorokin; Anton Buzdin; Katherine A Fitzgerald; Alexander Poltorak
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

Review 6.  RIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review).

Authors:  Yuping Liu; Ting Liu; Tiantian Lei; Dingding Zhang; Suya Du; Lea Girani; Dandan Qi; Chen Lin; Rongsheng Tong; Yi Wang
Journal:  Int J Mol Med       Date:  2019-06-14       Impact factor: 4.101

7.  Transcriptome Analysis Reveals Possible Immunomodulatory Activity Mechanism of Chlorella sp. Exopolysaccharides on RAW264.7 Macrophages.

Authors:  Siwei Wu; Hongquan Liu; Siyu Li; Han Sun; Xiumiao He; Ying Huang; Han Long
Journal:  Mar Drugs       Date:  2021-04-14       Impact factor: 5.118

Review 8.  A New Venue of TNF Targeting.

Authors:  Sophie Steeland; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Int J Mol Sci       Date:  2018-05-11       Impact factor: 5.923

9.  Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.

Authors:  Fanghong Mou; Canglang Mou
Journal:  Med Sci Monit       Date:  2020-02-05

Review 10.  The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer.

Authors:  Laura Della Torre; Angela Nebbioso; Hendrik G Stunnenberg; Joost H A Martens; Vincenzo Carafa; Lucia Altucci
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.